Administration of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP), a neurotoxin highly selective for midbrain dopamine neurons, to nonhuman primates produces a pattern of dopamine neuron loss and movement disorders similar to that seen in Parkinson's disease. In both idiopathic parkinsonism and MPTP-induced parkinsonism, the functional state of residual midbrain dopamine neurons is unclear. This proposal focuses on characterizing the structural and functional properties of residual dopamine neurons before and after exposure to glial cell line-derived neurotrophic factor (GDNF), a potent dopaminergic trophic factor which induces functional recovery in parkinsonian monkeys. In this project, the PI will specifically aim to test the following hypotheses: 1) That GDNF exerts neurorestorative effects on MPTP-injured dopamine neurons in the adult brain. Changes in the characteristics of surviving substantia nigra dopamine neurons following GDNF treatment will be analyzed using an optical dissector/stereological cell counting approach to determine cell number and quantitative image analysis to measure cell size. 2) That improvements in parkinsonian features following GDNF administration correlate closely with the upregulation of dopamine markers such as tyrosine hydroxylase and the dopamine transporter in midbrain dopamine neurons. 3) That intracerebral administration of GDNF significantly alters nigrostriatal dopamine metabolism. Basal levels of dopamine and its metabolites, characteristics of potassium-evoked dopamine release and high affinity dopamine uptake will be analyzed in the putamen and substantia nigra of GDNF-treated and vehicle-treated parkinsonian rhesus monkeys using iv vivo microdialysis techniques. These studies should increase the understanding of the properties of residual midbrain dopamine neurons in nonhuman primates with MPTP-induced parkinsonism.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS035642-03
Application #
2750956
Study Section
Neurology B Subcommittee 2 (NEUB)
Program Officer
Oliver, Eugene J
Project Start
1996-09-01
Project End
2000-07-31
Budget Start
1998-08-01
Budget End
2000-07-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
832127323
City
Lexington
State
KY
Country
United States
Zip Code
40506
Zhang, Z; Andersen, A; Smith, C et al. (2000) Motor slowing and parkinsonian signs in aging rhesus monkeys mirror human aging. J Gerontol A Biol Sci Med Sci 55:B473-80
Zhang, Z; Andersen, A H; Avison, M J et al. (2000) Functional MRI of apomorphine activation of the basal ganglia in awake rhesus monkeys. Brain Res 852:290-6
Zhang, Z; Zhang, M; Ai, Y et al. (1999) MPTP-Induced pallidal lesions in rhesus monkeys. Exp Neurol 155:140-9
Gash, D M; Zhang, Z; Umberger, G et al. (1999) An automated movement assessment panel for upper limb motor functions in rhesus monkeys and humans. J Neurosci Methods 89:111-7
Gash, D M; Zhang, Z; Gerhardt, G (1998) Neuroprotective and neurorestorative properties of GDNF. Ann Neurol 44:S121-5
Kearns, C M; Cass, W A; Smoot, K et al. (1997) GDNF protection against 6-OHDA: time dependence and requirement for protein synthesis. J Neurosci 17:7111-8